Introduction {#Sec1}
============

Hydrogen sulfide (H~2~S) has gained acceptance by researchers, as the third gaseous mediator identified in mammals alongside nitric oxide (NO) and carbon monoxide (CO). Over the past decade, this molecule has been shown to be synthesised by a range of tissues in which it functions as a signalling molecule with distinct physiological and biochemical effects \[[@CR1]--[@CR3]\]. To date, the spectrum of signalling systems identified include, but is not restricted to, nuclear factor-kappa beta (NF-κB), the activity of several kinases, including p38 mitogen-activated protein kinase (p38 MAPK) \[[@CR4]\], c-JunNH~2~-terminal kinase (JNK) \[[@CR5]\], extracellular signal-regulated kinase (ERK) \[[@CR6]\], phosphoinositide 3-kinase-protein kinase B (PI-3K-Akt) \[[@CR7]\], protein kinase C (PKC) \[[@CR8]\], nuclear factor erythroid 2-related factor 2 (Nrf-2) \[[@CR9]\], p53 \[[@CR10]\], AMP-activated protein kinase \[[@CR11]\], proliferator-activated receptor γ \[[@CR12]\], NAD-dependent deacetylase sirtuin-1 (SIRT1) \[[@CR13]\], SIRT3 \[[@CR14]\], and mechanistic target of rapamycin (mTOR) \[[@CR15]\]. Studies focused on delineating these molecular networks have revealed H~2~S to have important roles in cytoprotection \[[@CR16]--[@CR20]\], inflammation \[[@CR21]--[@CR24]\], vascular function \[[@CR25]--[@CR27]\], neurological systems \[[@CR28]\], tissue repair and healing \[[@CR29]--[@CR34]\], apoptosis and the cell cycle \[[@CR35], [@CR36]\], mitochondrial function and energy metabolism and biogenesis \[[@CR37]--[@CR48]\], obesity \[[@CR49]--[@CR53]\], and in ageing \[[@CR54]--[@CR60]\]. What function H~2~S which plays in these processes ranges from its ability to act as an antioxidant during episodes of elevated free-radical production \[[@CR61], [@CR62]\] to direct post-transcriptional modification of cellular proteins via S-sulfhydration \[[@CR63], [@CR64]\]. In practise, the signalling effects of H~2~S are more complex due to the fact that this gas readily interacts with other signalling molecules, such as reactive oxygen and nitric-oxide species \[[@CR65]--[@CR67]\]. Aside from enzymatic routes of synthesis, recent evidence has also shown indirect or secondary sites of H~2~S production. These sites include the endogenous liberation from persulfides and polysulfide species, both endogenous and dietary derived, along with bacterial sources present within the gastrointestinal tract \[[@CR68]--[@CR79]\]. How these pools of H~2~S are coordinated within localised, as well as distal sites, and how these systems influence disease pathology and longevity in mammals is one of the key questions currently being explored by researchers in this field.

H~2~S biosynthesis and catabolism {#Sec2}
=================================

Biosynthetic and degradative pathways involved in H~2~S production and consumption are largely mediated by cystathionine β synthase (CBS, EC 4.2.1.22), cystathionine-γ-lyase (CSE, EC 4.4.1.1), 3-mercaptopyruvate sulfurtransferase (3-MST, EC 2.8.1.2), ethylmalonic encephalopathy protein 1 (ETHE1, EC: 1.13.11.18), mitochondrial sulfide--quinone oxidoreductase (SQR, EC 1.8.5.4), and cysteine dioxygenase (CDO, EC: 1.13.11.20) (Fig. [1](#Fig1){ref-type="fig"}). Biochemical and pharmacological aspects relating to these enzymatic systems have recently been covered in great detail \[[@CR80], [@CR81]\] and will, therefore, only be touched upon herein. Moreover, whilst the roles of ETHE1, SQR, and CDO may not appear obvious at first sight, their potential influence on H~2~S tissue levels, via catabolic effects on either H~2~S directly or on the amino-acid cysteine justifies inclusion. Since the potential importance of these enzymes has, until now, been largely ignored, we believe that some discussion is warranted, if only at the very least, to stimulate debate and hopefully encourage future studies using the available murine genetic knockout models. Furthermore, the possibility of the existence of polymorphisms linked to genes encoding H~2~S detoxification enzymes is intriguing. How such variants influence tissue H~2~S turnover rates and physiological effects remains largely unexplored. Thus, the expression levels and catabolic effects of each of these enzymes may well influence exposure levels of cells, tissues, and organs to this biologically active gas. It is for this reason that these systems will be described across physiologically relevant models, including the mouse, *Mus musculus,* and to a lesser extent in *Caenorhabditis elegans*, *Drosophila melanogaster,* and *Danio rerio*. Collectively, these models will pave the way to a better understanding of the biological significance of this gaseous molecule and could potentially assist in the development of future pharmacologically active entities. The review will also address some of the recent findings relating to H~2~S biology in which genetic approaches, including gene knockdown and genetic model systems, have been employed to explore the functional role of this gas.Fig. 1Generalised overview of H~2~S production and degradation within mammalian tissues. The dietary amino acids, methionine and cysteine, serve as the primary substrates for the trans-sulfuration pathway and in the production of H~2~S. The levels of H~2~S within cells and tissues will be governed by the rates of synthesis by the enzymes cystathionine β synthase (CBS, EC 4.2.1.22), cystathionine-γ-lyase (CSE, EC 4.4.1.1), 3-mercaptopyruvate sulfurtransferase (3-MST, EC 2.8.1.2), versus the rates of oxidation and detoxification by the enzymes ethylmalonic encephalopathy protein 1 (ETHE1, EC: 1.13.11.18) and sulfur:quinone oxidoreductase (SQR, EC 1.8.5.4). Alternatively, the levels of the substrate cysteine may be depleted via the catabolic actions of cysteine dioxygenase (CDO, EC: 1.13.11.20)

Pharmacological approaches to manipulate H~2~S levels within biological systems {#Sec3}
===============================================================================

In general, our current understanding of H~2~S biology has arisen from work focused on enzymes of the trans-sulfuration pathway. For detailed coverage of the biochemical aspects relating to these enzymatic systems, we refer interested readers elsewhere \[[@CR82]--[@CR84]\]. By and large, the maintenance of the cellular H~2~S homeostatic equilibrium is governed by a small group of enzymes that are involved in the catabolism of the amino-acid cysteine, namely, CBS, CSE, and 3-MST. Both CBS and CSE appear to be the major enzymatic routes for the production of H~2~S within biological systems. Tissue specific expression of CBS predominates in the brain, nervous system, liver, and kidney, while CSE is expressed in the liver and in vascular and non-vascular smooth muscle. However, recent studies have reported on the expression of CBS in HUAEC cells, the uterine artery, mesenteric artery, and carotid body \[[@CR85]\]. Furthermore, the expression of CBS in the uterine artery was found to be stimulated at the hormonal level \[[@CR86]\]. This finding suggests a critical role for H~2~S within the reproductive tract. 3-MST is localised to mitochondria and produces H~2~S in a coupled reaction with the enzyme cysteine aminotransferase \[[@CR87]\]. Information on the degradative and detoxification routes for H~2~S within biological systems is less widely reported. What is known is that the degradation or loss of tissue H~2~S appears to occur via a number of distinct pathways that likely working in concert. For example, chemical processes, such as (1) the direct oxidation of H~2~S to thiosulfate in the presence of O~2~ and transition metals or (2) via enzymatic processes that include SQR and ETHE1 systems \[[@CR88]--[@CR91]\]. Functional roles for the enzymes rhodanese (EC 2.8.1.1) and sulfite oxidase (EC 1.8.3.1) have also been proposed, yet data are currently lacking for these detoxification routes \[[@CR92]--[@CR95]\]. For many studies, manipulation of cellular and tissue levels of H~2~S is required and historically, this has been achieved utilising inhibitor and/or donor molecules targeting the H~2~S biosynthetic pathway (Fig. [2](#Fig2){ref-type="fig"}). The widely used CSE inhibitor, [dl]{.smallcaps}-proparylglycine, for example, can increase disease severity in animal models of colitis \[[@CR96]\], myocardial ischemia--reperfusion-induced injury \[[@CR97]\], and also has anti-hyperalgesic effects \[[@CR98]\] and has reported inflammatory as well as anti-inflammatory effects in rodent models \[[@CR21]\]. These studies indicate that the inhibition of H~2~S biosynthetic enzymes, and therefore, the production of H~2~S within tissues and cells typically leads to increased disease severity which effects are reversed by the use of H~2~S donor molecules. To date, several pharmacological inhibitors are now available for use in this field, including hydroxylamine (HA), trifluoroalanine, aminooxyacetate (AOAA) (for CBS), and [d,l]{.smallcaps}-propargylglycine (PAG) or β-cyanoalanine (BCA) (for CSE), that have provided a means to manipulate tissue H~2~S levels \[[@CR99]--[@CR103]\]. Other newer inhibitory molecules with greater specificity and enhanced potency have also been characterized, but sadly, many of these are not currently commercially available. For instance, in the work of Thorson, a marine invertebrate compound library consisting of 160 characterized marine natural products and 80 purified synthetic derivatives aided in the identification of several small molecular weight inhibitors of CBS with IC~50~ values below 200 μM (range 83--187 μM) \[[@CR104], [@CR105]\]. So far, a number of similar library-based screening approaches have proven fruitful in the identification of novel inhibitory molecules targeting CSE, CBS, and/or both. Indeed, Zhou and colleagues have utilised a tandem well-plate screening system to assess potential inhibitory molecules that target CSE and CBS. This approach involved screening 21599 chemical entities that lead to the identification of several potent inhibitory molecules designated NSC111041, NSC67078, and SP14311008 \[[@CR106]\]. Interestingly, NSC111041 and SP14311008 appear to target these enzymes at sites distal to the PLP binding site. This finding could perhaps serve to assist in the development of new classes of inhibitory molecules. Lastly, the pharmacological targeting of 3-mercaptopyruvate sulfotransferase is less widely reported, however, several inhibitor molecules have been identified base on their abilities to affect the rate of enzyme catalyzed thiocyanate formation in vitro. This structurally diverse class of inhibitor molecule includes hypotaurine, methanesulfinic acid along with pyruvate, phenylpyruvate, oxobutyrate, and oxoglutarate \[[@CR107]\]. These molecules appear to inhibit 3-MST in a concentration-dependent manner and have been determined to be uncompetitive inhibitors of 3-MST with respect to 3-mercaptopyruvate \[[@CR108], [@CR109]\]. Typical IC~50~ values for all three alpha-keto acids ranging between 9.5 and 13.7 mM. In spite of this information, no direct confirmation of their inhibitory action towards 3-MST and it ability to generate H~2~S has been reported.Fig. 2Over the last 10 years, a wide range of H~2~S donor molecules have been developed to assist in determining the biological effects of H~2~S under differing physiological and pathophysiological states. **a** H~2~S donor molecules commonly used experimentally as research tools to manipulate cellular levels of H~2~S gas. **b** Structures of several inhibitor molecules that target CBS and CSE

Genetic evidence for a role of CBS, CSE, and 3-MST in health and disease {#Sec4}
========================================================================

The established roles for CBS, CSE in sulfur amino-acid metabolism are widely recognised \[[@CR110]--[@CR112]\] and it is of interest that a number of polymorphisms in the genes coding for these proteins are linked to a range of pathophysiological conditions in humans \[[@CR113], [@CR114]\]. For example, there are an estimated 150 mutations in the CBS locus and of these approximately 20 appear to have altered enzymatic activity \[[@CR115]\]. A consequence for this loss often being homocystinuria \[[@CR116]\]. Interestingly, the CBS T833C variant has been associated with premature coronary artery disease \[[@CR117]\], essential hypertension \[[@CR118]\], and an increased risk of stroke \[[@CR119]\]. Similarly, the CBS 844ins68 polymorphism is linked to increase risk of breast cancer \[[@CR120]\], spontaneous cervical artery dissections \[[@CR121]\], raised plasma homocysteine levels \[[@CR122]\], and elevated homocysteine--thiolactone concentrations \[[@CR123]\]. Homocysteine--thiolactone is pro-atherogenic \[[@CR124], [@CR125]\], and can promote optic lens dislocation \[[@CR126]\]. Of equal interest, are polymorphisms linked to the CSE gene that predispose individuals to hypertension \[[@CR127]\] and in some cases raised plasma homocysteine levels \[[@CR128]\]. Several of these polymorphisms have been described in patients with cystathioninuria, and a single nucleotide polymorphism in CSE, c.1364G\>T, is linked to elevated plasma homocysteine levels \[[@CR128]\]. The influence of the rs1021737 and rs482843 CSE polymorphisms in preeclampsia has been raised \[[@CR129]\], and a proposed role in the development of chronic hypertension reported \[[@CR111]\]. Importantly, many of these polymorphic variants have reduced *V* ~max~ for the substrate cystathionine \[[@CR130]\]. Polymorphisms linked to the 3-MST gene are also known and the recent characterisation of a nonsense mutation (Tyr85Stop) that leads to the production of a severely truncated protein lacking enzymatic activity has been described \[[@CR131]\]. In spite of the information relating to H~2~S biosynthetic enzymes, data are currently lacking as to whether these polymorphic variants influence H~2~S biosynthetic rates. However, supporting evidence would indicate that this may be the case. Research utilising site-directed mutagenesis studies of the CBS protein has identified several key cysteine residues that are directly involved in the regulation of basal CBS activity and in H~2~S production \[[@CR132]\], and changes in the CBS binding site of the allosteric activator S-adenosylmethionine reduce H~2~S synthesis by this enzyme \[[@CR133]\]. Similarly, several amino-acid residues in CSE have been identified that are actively involved in H~2~S production \[[@CR134]\]. Therefore, the possibility that known polymorphisms for CBS, CSE, and 3-MST would influence enzymatic activity of these proteins, and therefore, tissue H~2~S levels is not unreasonable.

Further circumstantial evidence linking impaired tissue biosynthesis rates of H~2~S and disease are provided from a range of additional sources. Loss of function in either CBS or CSE can increase the risk of individual developing cardiovascular diseases. Moreover, decreased H~2~S production rates in mice predispose animals to vascular remodeling, hypertension, and early the development of atherosclerosis. Therefore, the idea that H~2~S may have an important function within the cardiovascular system and at other sites is not a new concept. Indeed, H~2~S and allied donor drugs can reduce homocysteine mediate cellular stress responses and tissue damage in mammalian systems \[[@CR135]--[@CR139]\]. In addition, it is widely recognised that H~2~S can directly affect blood pressure, alter lipid metabolism, inhibit monocytes adhesion and activate the endothelium \[[@CR140], [@CR141]\], promote vasorelaxation \[[@CR142]\], and induce angiogenesis \[[@CR143]\]. H~2~S also mediates vascular smooth muscle cell proliferation, migration, and apoptosis \[[@CR144]--[@CR146]\], inhibits macrophage foam cell formation \[[@CR147]\], chemotaxis \[[@CR148]\], and inflammation \[[@CR23], [@CR149]\], and decreases vascular calcification \[[@CR150]\], platelet aggregation, and thrombogenesis \[[@CR151], [@CR152]\] (reviewed in \[[@CR153], [@CR154]\]). Importantly, in humans, decreased plasma H~2~S concentrations are found to correlate with the activation of protein kinase CβII in uremic accelerated atherosclerosis patients \[[@CR155]\] and in chronic haemodialysis patients with diabetic nephropathy \[[@CR156]\]. Diminished levels of plasma H~2~S are also reported to be significantly lowered in CHD patients and in smokers as compared to normal subjects \[[@CR157]\], in essential hypertensive children suffering from a metabolic imbalance of homocysteine and hydrogen sulfide \[[@CR158]\], and are decreased in patients on chronic haemodialysis due to reduced CSE expression \[[@CR159]\]. Lower H~2~S levels also correlate with the accumulation of lanthionine in the blood of uremic patients \[[@CR160]\]. These changes potentially contribute to hyperhomocysteinemia in uraemia. Intriguingly, homocysteine has been reported to decrease H~2~S production in macrophages by increasing promoter DNA methylation and transcriptional repression of CSE \[[@CR161]\]. In addition, the cardioprotective effects of atorvastatin appear to be partly mediated by the effects of this drug on the expression of CSE and associated increases in the generation of H~2~S \[[@CR162]\]. Therefore, from the available evidence, it is clear that multiple pathologies and mechanisms underpin these diseases, but, intriguingly, a lack of H~2~S production seems to be at least one common thread. For this reason, the characterisation of gene polymorphisms linked with enzymes associated with H~2~S synthesis and its degradation requires further exploration. This could provide a greater understanding of how such polymorphisms influence enzymatic function and this may, in the future, be found to translate to changes in circulatory H~2~S levels. A key question is how do changes in the expression levels of enzymes involved in H~2~S homeostatic regulation, and their associated mutations cause disease and what are the molecular mechanisms responsible for this? To answer these questions, new approaches that include genetic models of H~2~S deficiency and/or overproduction have been adopted. Specifically, knockout animals lacking genes encoding for CSE, CBS, 3-MST, CDO and ETHE1. In the case of studies utilising these models, a greater understanding of how H~2~S functions as a signalling molecule and how this translates to influencing physiological and biochemical processes in vivo is pushing the boundaries of our current views for this gas. Importantly, findings from such work may provide routes for patient screening prior to pharmacological intervention with H~2~S releasing drugs to restore H~2~S levels.

Molecular approaches to alter H~2~S biosynthetic capacity in cells and animals {#Sec5}
==============================================================================

In addition to pharmacological approaches to alter tissue H~2~S concentrations, a number of researchers have adopted siRNA methodologies to assist in loss of function studies by targeting H~2~S biosynthetic enzyme expression levels. These techniques have been particularly amenable for use in cell-culture systems. As shown in Table [1](#Tab1){ref-type="table"}, these approaches have assisted researchers in the manipulation of the expression levels of enzymes involved in H~2~S homeostatic regulation across a range of cell types. These technologies, while technically more challenging, have shown that H~2~S is involved in cellular proliferation and apoptosis \[[@CR146]\], endoplasmic reticulum stress, and insulin secretion \[[@CR176]\], and NF-κB and MAP kinase signalling and inflammation in macrophages \[[@CR166], [@CR167]\]. Curiously, the silencing of 3-MST has revealed this enzyme to be involved in the H~2~S production that in turn supports mitochondrial bioenergetics \[[@CR39], [@CR40]\]. Currently, siRNA and shRNA systems targeting CSE and CBS can be obtained from a range of commercial suppliers, including, but not exclusively by, CAYMAN chemicals, Addgene (Cambridge, MA, USA), and Santa Cruz Biotechnology (Texas, USA) or can be custom synthesised by IDT DNA technologies (Glasgow, UK).Table 1Studies utilising cell-culture models to explore the loss of function or overexpression of H2S synthesising enzymesDisease modelTransgenic systemCell typeConsequenceReferencesCystathionine gamma lyase CVDCSE adenovirus gene transferStably CSE overexpression in HEK-293 cellsIncreases in CSE mRNA levels, CSE proteins, leading to increased intracellular production rates of H~2~S. This correlated with the inhibition of cell proliferation and DNA synthesis. Sustained ERK activation and upregulation of the cyclin-dependent kinase inhibitor p21Cip/WAK^−1^ was also noted\[[@CR163]\]CSE adenovirus gene transferStably CSE overexpression in Human aorta smooth muscle cellsIncrease in the expression of CSE protein and a committed increase in H~2~S production rates. Cell growth inhibition and the induction of apoptosis noted in CSE overexpressing cells. Apoptosis was associated with an increased in ERK and p38 MAPK activation, upregulation of p21(Cip/WAK-1), and downregulation of cyclin D1 expression. Inhibiting endogenous background CSE gene expression, and direct administration of H~2~S at 100 microM induced apoptosis in HASMCs\[[@CR146]\]Transfected with miR-30 mimicsHEK293 cells and primary neonatal rat myocardial cellsOverexpression of miR-30 family members decreases the expression of CSE protein and H~2~S production. Reduced CSE expression sensitised cells to hypoxic conditions. Overexpression of CSE was cytoprotective in this model. Knockdown of miR-30 family members leads to the upregulation of CSE and H~2~S production rates\[[@CR164]\] DiabetesCSE adenovirus gene transferTransfection of insulin secreting beta cell line INS-1E cellsCSE overexpression stimulates INS-1E cell apoptosis via increased endogenous production of H~2~S. Ad-CSE transfection inhibited ERK1/2 but activated p38 MAPK. Overexpression of CSE or H~2~S treatment increased BiP and CHOP levels indicators of endoplasmic reticulum (ER) stress\[[@CR176]\] InflammationsiRNA targeting mouse CSEMurine Raw264.7 macrophages and primary macrophage isolated from adult male C57BL/6 miceCSE overexpression reduced the ox-LDL-stimulated tumor necrosis factor-α (TNF-α) generation in Raw264.7 and primary macrophage while CSE knockdown enhanced it\[[@CR149]\]siRNA targeting mouse CSEHuman chondrocytes and mesenchymal progenitor cellsCBS- and CSE-siRNA treatment sensitises cells to oxidative stress leading to loss of cell viability as determined using the MTT assay. [l]{.smallcaps}-cysteine, a substrate for CSE and CBS, fails to protect against SIN-1, H~2~O~2~ and 4-HNE induced cell death in chondrocytes in silenced cells\[[@CR165]\]siRNA targeting mouse CSEMurine RAW 264.7 macrophagesLipopolysaccharide (LPS) treatment of RAW 264.7 cells promotes increased CSE mRNA and protein levels along with increased production of proinflammatory cytokines (TNF-α, IL-1β, IL-6, and MCP-1) and nitric oxide (NO). Silencing of CSE reduced proinflammatory mediator levels and enhanced NO production\[[@CR166]\]siRNA targeting mouse CSEMurine RAW 264.7 macrophagesCSE silencing reduced inflammation status by attenuating the activity of NF-κB in lipopolysaccharide- (LPS-) stimulated macrophages. Reduced production of inflammatory mediators via inhibition of extra cellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation\[[@CR167]\] PreeclampsiasiRNA targeting mouse CSE and adenovirus gene transferHuman umbilical vein endothelial cells (HUVEC)Downregulation of CSE results in an increased release of soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin (sEng); both proteins involved in angiogenesis. Overexpression of CSE results in the inhibition of sFlt-1 and sEng release\[[@CR168]\] OsteoporosissiRNA targeting mouse CSEBone marrow mesenchymal stem cells (BMMSCs)Knockdown of CSE lead to increased cell proliferation, reduced capacity for forming mineralized nodules in vitro, and downregulation of Runx2 and ALP. Reduction of H~2~S levels resulted in a cascade response in BMMSCs, including altered Ca^2+^ channel sulfhydration, Ca^2+^ influx, Wnt/β-catenin signaling, and osteogenic differentiation\[[@CR169]\]siRNA targeting mouse CSEMurine RAW 264.7 macrophagesCSE silencing inhibited osteoclast formation by reducing the expression of the typical osteoclast markers, Cathepsin K, TRAP and MMP9\[[@CR229]\]Disease modelTransgenic systemModel systemConsequenceReferencesCystathionine-beta synthetase CVDTransfected with CBS cDNA subcloned into the plasmid pcDNA3Mouse aortic endothelial cells (MAEC)Transfection of endothelial cells with cystathionine-beta-synthase (CBS) reduced Hcy accumulation in high methionine-fed cells. Reduced inflammatory response, as evident by attenuated ICAM-1 and VCAM-1 expression and reduced expression of collagen type-1 expression and MMP-9 activity\[[@CR170]\]Lentiviral CBS-targeting short hairpin RNA (shRNA)Human umbilical vein endothelial cells (HUVEC) and human aortic endothelial cells (HAEC)CBS knockdown reduced cell proliferation in both HUVEC and HAEC cells. Expression of p21^WAF-1^ and γ-H~2~AX, both molecular markers of senescence, were induced along with positive staining for β-galactosidase (SA-β-gal). Loss of CBS induces premature endothelial cell senescence\[[@CR171]\]CancersiRNA targeting mouse CBSA2780, A2780/CP-70, OV202 and SKOV3 human ovarian carcinoma cellsOvarian cancer cell proliferation was decrease upon CBS silencing as determined via (^3^H)-thymidine incorporation. In CBS silenced A2780 cells cellular ROS levels increase and glutathione levels significantly decrease. Expression of p53 is also induced in A2780 cells with the RelA/p65 subunit of NF-κB showing decreased expression\[[@CR172]\]siRNA targeting mouse CBSHuman colonic epithelial cancer cell line HCT116Silencing lead to a reduction of CBS expression and associated reductions in H~2~S production and cell proliferation. Reduction in ATP synthesis, basal cellular respiration and spare respiratory capacity. A significant reduction in the density of CD31-positive blood vessels within tumour tissue and an increase in vessel branching. Reduced glycolytic functions, possibly due to inhibition of GAPDH activity\[[@CR173]\]siRNA targeting mouse CBSTransfection of immortalized Jurkat human T-lymphocyte cellsReduced expression of CBS mRNA significantly impaired both CD69 and IL-2 expression in TCR-activated T cells and resulted in decreased adhesion, which could be partially rescued by the addition of exogenous H~2~S\[[@CR174]\]Lentiviral CBS-targeting short hairpin RNA (shRNA)Human breast cancer cells MCF7 and MDA-MB-468Silencing of CBS increased the steady state levels of adducts 4-HNE and MDA protein in HBC cells. When co-cultured with activated macrophages, HBC cell growth was compromised by CBS silencing\[[@CR175]\]3-Mercaptopyruvate sulfurtransferase BioenergeticsMitochondrial Bioenergetics; isolated mitochondria and hepa1c1c7 cells3-MST mediated stimulation of H~2~S production is reduced in siRNA and shRNA mediated KO of 3-MST. Loss of a functional 3-MST protein correlated with reduced cellular bioenergetics in hepatoma cells, reduced oxygen consumption and H~2~S production rates\[[@CR40]\] CVDp-plasmid cytomegaloviral promoter DNA vector system (pcDNA/GFP)Mouse aortic endothelial cellsMAEC cells transfected with CSE, CBS, MST or gene triplicate. 3-MST overexpression localised to mitochondria with 3MST-transfected cells produced increased amount of H~2~S compared with nontransfected cells. Mitigates Hcy-induced mitophagy and ROS production\[[@CR137]\]

In vivo knockout models of H~2~S research {#Sec6}
=========================================

Over the last two decades, much has been learnt regarding the biological roles ascribed to H~2~S, yet many questions still remain to be answered. Indeed, little is known regarding the compensatory mechanisms that may exist to maintain physiological levels of H~2~S nor the interplay between biosynthetic routes and the recently characterised detoxification pathways involving ETHE1 and SQR. Establishing links between these two metabolic processes will be important in the future developed of pharmacologically active drugs and inhibitor molecules that target the H~2~S system. The possibility that inhibitors targeting ETHE1 or SQR could offer an alternate means to manipulate H~2~S levels is intriguing. These approaches will most certainly require work within whole physiological systems and perhaps in this instance in the use of transgenic mouse models in which genes encoding for H~2~S synthesising enzymes have been manipulated. Of relevance here then are the approaches taken to generate mice devoid of H~2~S biosynthetic enzymes as described previously \[[@CR177]--[@CR180]\] (reviewed in \[[@CR113]\]).

Cystathionine-β-synthase knockout mouse models {#Sec7}
==============================================

Watanabe and colleagues were the first group to report on the generation of a CBS deficiency mouse line using gene targeting of embryonic stem (ES) cells followed by incorporation into C57BL/6J mice. This early work establishes an in vivo system to explore aspects relating to homocysteine and its associated pathophysiological effects in cardiovascular diseases. Homozygous animals completely lacked CBS and mice suffer from severe homocysteinemia, have severe growth retardation and many die within 5 weeks following birth. Heterozygous animals show greater viability and have a 50% reduction in CBS expression and enzyme activity in the liver and have twice normal plasma homocysteine levels. Studies using this model are, therefore, restricted to younger animals and may consequently be influenced by the age-dependent expression of other H~2~S biosynthetic enzymes, such as CSE. For this reason, some authorities have called into question the use of this model \[[@CR177]\].

Problems associated with early lethality in the CBS model were later overcome by the work of Wang et al. \[[@CR178], [@CR179]\]. In the first approach taken by this group, mice were produced with the aim of overexpressing CBS. This was achieved using a transgenic system in which the human CBS cDNA was placed under the control of the zinc-inducible metallothionein promoter (Tg-CBS). Zinc supplementation in Tg-CBS mice causes a two--four-fold increase in liver and kidney CBS activity and a 45% decrease in serum homocysteine levels. In contrast to previous model systems, these animals do not develop hepatic steatosis, fibrosis, or suffer from high rates of neonatal death. The second approach was to engineer mice that express the human I278T and I278T/T424N mutant CBS proteins under the control of a metallothionein driven transgene. These animals were rescued from early lethality yet still showed severe elevations in both plasma and tissue levels of homocysteine, methionine, *S*-adenosylmethionine, and *S*-adenosylhomocysteine and a concomitant decrease in plasma and tissue levels of cysteine \[[@CR178]\]. Finally, MacClean and colleagues developed a mouse model null for the mouse CBS gene that carried copies of the human CBS gene expressed at low levels \[[@CR180]\]. So far, CBS KO models have supported a range of studies focused on folate metabolism \[[@CR181], [@CR182]\], blood brain barrier function \[[@CR183]\], endothelial dysfunction \[[@CR184]\], cerebral vascular dysfunction \[[@CR185]\], brain function linked to changes in the SAPK/JNK signalling pathway \[[@CR186]\], redox homeostasis \[[@CR187]--[@CR189]\] microvascular remodelling \[[@CR190]\], blood--brain barrier integrity \[[@CR191]\], lung fibrosis \[[@CR192]\], lipid homeostasis \[[@CR193]--[@CR195]\], retinal neuron death \[[@CR196]\], infertility \[[@CR197], [@CR198]\], and susceptibility to drug induced toxicity \[[@CR199]\]. Of relevance here then is the growing body of work indicating that H~2~S plays a part in many of these processes.

Cystathionine γ-lyase knockout mouse models {#Sec8}
===========================================

So far, the most widely used animal system in H~2~S research is the CSE-KO model. To date, CSE-KO animals have been utilised to explore the role of H~2~S within the cardiovascular disease \[[@CR204]\], diabetes \[[@CR200], [@CR201], [@CR213]\], and in studying interactions of H~2~S with other important gaseous signalling molecules, such as nitric oxide \[[@CR202]\]. The production of viable and fertile CSE-KO animals was first reported in the work of Yang et al. In these homozygous animals, CSE mRNA and protein levels were absent in heart, aorta, mesenteric artery, liver, and kidneys. Importantly, both tissue and serum levels of H~2~S were significantly reduced in KO animals with this correlated with an age-dependent increase in blood pressure and impaired endothelium-dependent vasorelaxation \[[@CR204]\]. This is in contrast to the CSE-KO model reported by Ishii et al. \[[@CR203]\], in which animals appeared both normotensive and hyperhomocysteinemic. Interestingly, these mice were extremely sensitive to sulfur amino-acid restriction and homozygous animals maintained on a low cysteine diet, succumbed to acute skeletal muscle atrophy, and reduced tissue glutathione levels and lethality. Hepatocytes isolated from these animals were also highly sensitive to oxidative stress. To date, the CSE-KO model developed by Yang has been widely used to explore the role of H~2~S across a range of pathophysiological conditions. These studies are summarised in Table [2](#Tab2){ref-type="table"} and include hypertension \[[@CR204]\], cellular proliferation \[[@CR205]\], oxygen sensing \[[@CR206]\], cellular senescence \[[@CR207]\] pressure overload heart failure \[[@CR208]\], asthma \[[@CR209]\], vasorelaxation \[[@CR210]\], ischemia/reperfusion injury \[[@CR202], [@CR211]\], atherosclerosis \[[@CR212]\], caerulein-induced acute pancreatitis \[[@CR213]\], postischemic cerebral vasodilation/hyperemia \[[@CR214]\], arteriogenesis \[[@CR215]\], pain \[[@CR216]\], gluconeogenesis \[[@CR217]\], M2 macrophage polarization \[[@CR45]\], antiviral effects \[[@CR218]\], and infiltration and migration \[[@CR219]\]. Particularly interesting are the functional aspects relating to interaction of H~2~S with other gaseous signalling molecules. It is now widely accepted that H~2~S and NO readily interact at physiological pH to produce a range of biologically active species \[[@CR65], [@CR220]--[@CR222]\]. An established link between NO and H~2~S has now been reported utilising the CSE-KO systems. Studies by Kondo and colleagues reported on the influence of H~2~S and its interaction with NO in a murine model of pressure overload-induced heart failure using CSE-KO animals \[[@CR208]\]. CSE knockout (KO) animals had reduced circulating H~2~S levels and cardiac dilatation and dysfunction. In this instance, H~2~S therapy was found to be cardioprotective. This corresponding with the upregulation of the VEGF-Akt-eNOS-nitric-oxide-cGMP pathway, preserved mitochondrial function, attenuated oxidative stress, and increased myocardial vascular density. Elevated oxidative stress, dysfunctional eNOS, diminished NO levels, and exacerbated myocardial and hepatic I/R injury are also reported for CSE-KO animals \[[@CR202]\]. Collectively, this work suggesting that H~2~S and NO interact and that H~2~S is particularly important in the regulation of NO within the cardiovascular system.Table 2Available CSE knockout mice models have been used to confirm a role of H~2~S across a wide range of pathophysiological modelsBiological processConsequenceReferencesVasorelaxation and hypertensionGenetic deletion of CSE in mice markedly reduces H~2~S levels in the serum, heart, aorta, and other tissues. Mutant mice lacking CSE display pronounced hypertension and diminished endothelium-dependent vasorelaxation\[[@CR204]\]Cell proliferation and apoptosisCSE-KO mice have lower levels of phosphorylated extracellular signal-regulated kinase (ERK1/2) in mesentery arteries. SMCs of KO animals display an increased proliferation rate in vitro and in vivo, and these cells are more susceptible to apoptosis\[[@CR205]\]O~2~ sensingDeletion of CSE severely impairs carotid body response and ventilatory stimulation to hypoxia, as well as a loss of hypoxia-evoked H~2~S generation\[[@CR206]\]Cellular senescenceMouse embryonic fibroblasts isolated from CSE knockout mice (CSE-KO-MEFs) display increased oxidative stress and accelerated cellular senescence. The protein expression of p53 and p21 is significantly increased in KO-MEFs, and knockdown of p53 or p21 reversed CSE deficiency-induced senescence\[[@CR207]\]Pressure overload-induced heart failureH~2~S levels are decreased in mice following heart failure. CSE plays a critical role in the preservation of cardiac function in heart failure\[[@CR208]\]AsthmaCSE expression was absent and H~2~S production rate significantly lower in the lungs of CSE-KO mice. CSE deficiency resulted in aggravated AHR, increased airway inflammation, and elevated levels of Th2 cytokines IL-5, IL-13, and eotaxin-1 in bronchoalveolar lavage fluid after OVA challenge\[[@CR209]\]Physiologic vasorelaxationCSE-KO induces elevated resting-membrane potential of SMCs and eliminated methacholine-induced endothelium-dependent relaxation of mesenteric arteries. H~2~S is an endothelium derived hyperpolarizing factor\[[@CR210]\]Renal ischemia/reperfusionCSE-KO mice have markedly reduced renal production of H~2~S, and CSE deficiency increases damage and mortality after renal ischemia/reperfusion injury as compared to wild-type mice\[[@CR211]\]AtherosclerosisDeficiency of CSE in mice leads to a decreased endogenous H~2~S levels, and age-dependent increase in blood pressure, and impaired endothelium-dependent vasorelaxation. CSE-KO animals fed with an atherogenic diet developed early fatty streak lesions in the aortic root, elevated plasma levels of cholesterol and low-density lipoprotein cholesterol, hyperhomocysteinemia, increased lesional oxidative stress and adhesion molecule expression, and enhanced aortic intimal proliferation\[[@CR212]\]Caerulein-induced acute pancreatitisCSE-KO mice showed significantly less local pancreatic damage as well as acute pancreatitis-associated lung injury compared with the WT mice. Lower levels of pancreatic eicosanoid and cytokines, as well as reduced acinar cell NF-κB activation in the CSE-KO mice\[[@CR213]\]Ischemia/reperfusion (I/R) injuryCSE-KO mice exhibit elevated oxidative stress, dysfunctional eNOS, diminished NO levels, and exacerbated myocardial and hepatic I/R injury. H~2~S therapy restored eNOS function and NO bioavailability and attenuated I/R injury\[[@CR202]\]Postischemic cerebral vasodilation/hyperemiaCSE-KO reduced postischemic cerebral vasodilation/hyperemia but only inhibited Na-F extravasation. Upregulated CBS was found in cerebral cortex of CSE-KO animals. L-cysteine-induced hydrogen sulfide (H~2~S) production is similarly increased in ischemic side cerebral cortex of control and CSE-KO mice\[[@CR214]\]ArteriogenesisFemoral artery ligation of WT mice significantly increased CSE activity, expression and endogenous H~2~S generation in ischaemic tissues, and monocyte infiltration. These being largely absent in CSE-KO mice. Treatment of CSE-KO mice with the polysulfide donor diallyl trisulfide restored ischaemic vascular remodelling, monocyte infiltration, and cytokine expression\[[@CR215]\]PainPaw inflammation and peripheral nerve injury causes the upregulation of CSE expression in dorsal root ganglia. CSE-KO mice demonstrated normal pain behaviours in inflammatory and neuropathic pain models. This finding suggestive that CSE is not critically involved in chronic pain signaling in mice and that sources different from CSE mediate the pain relevant effects of H~2~S\[[@CR216]\]GluconeogenesisCSE-KO mice reduced gluconeogenesis, which was reversed by administration of NaHS (an H~2~S donor). H~2~S upregulates the expression levels of peroxisome proliferator-activated receptor-γ coactivator-1α and phosphoenolpyruvate carboxykinase. Upregulation of PGC-1α is mediated via the GR pathway and through the activation of the cAMP/PKA pathway. PGC-1α, and the activities of glucose-6-phosphatase and fructose-1,6-bisphosphatase are increased via S-sulfhydration\[[@CR217]\]Mitochondrial biogenesis-dependent M2 polarization of macrophagesH~2~S supplementation ameliorated pathological remodeling and dysfunction post-MI in WT and CSE-KO mice. Decreased infarct size and mortality, accompanied by an increase in the number of M2-polarized macrophages at the early stage of MI. H~2~S induced M2 polarization was achieved by enhanced mitochondrial biogenesis and fatty acid oxidation\[[@CR45]\]AntiviralH~2~S has antiviral and anti-inflammatory activity in respiratory syncytial virus (RSV) infection. CSE-KO mice showed significantly enhanced RSV-induced lung disease and viral replication compared to wild-type animals. Intranasal delivery of GYY4137 to RSV-infected mice significantly reduced viral replication and markedly improved clinical disease parameters and pulmonary dysfunction\[[@CR219]\]Infiltration and migrationIncreased infiltration of macrophages into the infarcted myocardium at early stage of MI cardiac tissues in CSE-KO mice. Treatment with the H~2~S donor NaHS enhances macrophage migration. This is achieved by accelerating internalization of integrin β1 and activating downstream Src-FAK/Pyk2-Rac pathway\[[@CR220]\]Many of these studies have shown that loss of H~2~S synthesising capacity within tissues significantly affects the cardiovascular system, metabolism, and recovery from stress insults. Such studies highlight a fundamental role of H~2~S in the regulation of cellular stress pathways and in physiological responses to stress

Several newer reports have focused on the overexpression of CSE within mammalian systems. For example, in the work of Elrod et al, a transgenic mouse model was developed in which CSE is overexpressed within cardiac tissues leading to increased myocardial levels of H~2~S \[[@CR37]\]. These mice had a reduction in infarct size following MI-R injury and were used to establish that a localised increase of H~2~S within cardiac tissues protects against myocardial infarction. Similarly, manipulation of CSE either via knockdown or overexpression in mammalian cells has also shed additional light on the cardioprotective effects of H~2~S. Wang and colleagues found that CSE overexpression reduces ox-LDL-stimulated tumor necrosis factor-α (TNF-α) generation in Raw264.7 and primary macrophage, while CSE knockdown enhanced it \[[@CR149]\]. Under pathophysiological conditions linked to CVD, Cheung et al. reported that overexpression of CSE reduces markers associated with atherosclerosis \[[@CR223]\]. Using transgenic ApoE knockout mice overexpressing CSE (Tg/KO), increased endogenous H~2~S production in aortic tissue was demonstrated that correlated with reduced atherosclerotic plaque sizes and reduced plasma lipid profiles in mice maintained on an atherogenic diet. Moreover, an upregulation in plasma glutathione peroxidase, indicative of reduced oxidative stress, and an increase in the expression of p-p53 and downregulation of inflammatory nuclear factor-kappa B (NF-κB) were noted \[[@CR223]\]. Decreased CSE expression and its influence on H~2~S metabolism and atherosclerosis are currently an active area of investigation. Utilising the CSE knockout mouse, Mani et al. revealed a functional role of the CSE enzyme in atherosclerosis development \[[@CR212]\]. In CSE-KO animals, maintained on an atherogenic diet, cholesterol levels were found to be twofold higher within the plasma of CSE-KO animals compared to the WT animals. Moreover, fatty acid streaks, atherogenic lesions, and reduced blood flow were seen in CSE-KO animals. In this instance, KO animals treated with NaHS for 12 weeks showed significant improvements in plasma lipid profiles and decreased atherosclerotic lesions thus confirming a role of H~2~S in atherosclerosis. Furthermore, by combining the CSE-KO with the ApoE-1 KO genetic background to produce a double KO system (DKO), the authors were again able to demonstrate reduced lesion formation in DKO animals when treated with NaHS \[[@CR212]\]. Thus, endogenous loss of CSE has been shown to increase disease severity across several independent studies utilising the CSE-KO model.

3-Mercaptopyruvate sulfurtransferase knockout mouse models {#Sec9}
==========================================================

The roles for both CBS and CSE and their part played in the production of H~2~S within biological systems have been broadly defined in recent years, yet the view that these two enzymes are perhaps the only ones responsible for maintaining physiological levels of H~2~S is rather simplistic. As mentioned, an additional enzymatic system is known, that of 3-MST \[[@CR224]\]. In view of this, efforts have been made to generate a 3-MST murine model that could potentially provide a detailed picture of how this enzyme functions and its role in diseases \[[@CR227]\]. From a biochemical perspective 3-MST is a multifunctional enzyme involved in (1) cysteine catabolism, since it catalyses the trans-sulfuration of the substrate 3-mercaptopyruvate to pyruvate and (2) functions in cyanide detoxification. Also, the protein has a potential redox function since in the presence of the oxidant hydrogen peroxide (H~2~O~2~), enzyme activity is inhibited \[[@CR225]\]. Oxidant-mediated inhibition appears to occur via the formation of a sulfenate (SO^−^) moiety at the catalytic site cysteine. Enzymatic activity can be re-established in the presence of reducing agents DTT or reduced thioredoxin but not the cellular antioxidant glutathione. Under conditions of mild oxidative stress, such as those found in physiological systems, 3-MST activity is reduced leading to a resultant increase in cysteine concentrations in vitro. Thus, the current views suggest that 3-MST serves as an antioxidant protein. The curious fact that this enzyme is localised to mitochondria has further bolstered work on this enzyme, especially given the known inhibitory effects of H~2~S on cytochrome c oxidase function \[[@CR226]\]. Ongoing work in this area has shown that 3-mercaptopyruvate stimulates mitochondrial H~2~S production that in turn stimulates electron transport and bioenergetics at low concentrations (10--100 nM). Conversely, siRNA-mediated silencing of 3-MST reduces basal bioenergetics and prevents the stimulatory effects of 3-MP on mitochondrial energetics. In this scenario, H~2~S can be seen to serve as an electron donor that functions as an inorganic source of energy that supports electron transport and ATP production in mammalian cells. Interestingly, oxidant-mediated stress reverses these effects in cells. Shibuya reported that that tissue levels and production of H~2~S within brain tissues were similar in CBS KO mice with this supporting the notion that an alternate H~2~S production system must exist within brain tissues \[[@CR87]\]. Indeed, this work confirmed that CBS was not the primary source of H~2~S within this organ. Further characterisation led to the realisation that two proteins work in concert to produce H~2~S within brain tissues, these being, cysteine aminotransferase and 3-MST respectively \[[@CR87]\]. While a 3-MST-KO model has been developed currently only one report exists citing the generation and utilised of this model. Nagahara et al. were the first to describe a homozygous (null) MST-knockout (MST-KO) mouse model \[[@CR227]\]. These mice have increased anxiety-like behaviour, with increased serotonin levels in the prefrontal cortex. In this instance, 3-MST was proposed to function as an antioxidant redox-sensing protein involved in maintaining cellular redox homeostasis.

Genetic models of H~2~S detoxification systems in animals {#Sec10}
=========================================================

Three major enzymatic routes for the removal of H~2~S from tissues are currently recognised these constituting the aforementioned proteins SQR, ETHE1, and CDO. At present, the sites and rates of H~2~S detoxification have been less well defined than that of the biosynthetic routes of production. However, these systems likely play an equally important function in maintaining physiologically relevant tissue concentrations of H~2~S. Changes in the expression levels of these proteins would alter the physiological concentrations of this sulfurous gas in vivo and therefore, the response of cells to exposure to this molecule. Even with their recognised association with H~2~S detoxification, only now are we beginning to see how these enzymes influence physiological levels of this gas.

Sulfide--quinone reductase-like protein knockout models {#Sec11}
=======================================================

In mammalian systems, sulfide is oxidized by the mitochondrial sulfide--quinone reductase-like protein (SQR), a homologue of bacterial sulfide--ubiquinone oxidoreductase (SQR), and fission yeast heavy metal tolerance 2 protein \[[@CR228]\]. This protein is involved in the transfer of an electron from sulfide to membrane intrinsic quinones \[[@CR229]\]. The process of sulfide oxidation, therefore, links sulfide catabolism to oxidative phosphorylation and the subsequent production of ATP. This whole process allowing for sulfide to be used as an inorganic substrate for the human electron transfer chain. SQR is a component of several mammalian tissues, and protein expression has been confirmed within heart, lung, colon, liver, kidney, thyroid, brain, leukocytes, and penis and testicles of mice and rats \[[@CR230]\]. Fractionation experiments revealed this protein to be localised to mitochondria. SQR mRNA levels can be increased following exposure to sulfide in T cells and also with increasing age within the kidney. This finding indicating that the expression levels of this protein show some plasticity that allows for SQR to respond to changes in tissue H~2~S levels. It is easy to envisage that changes in SQR protein levels would influence H~2~S oxidation rates and the role of H~2~S in the production of ATP, ROS formation, oxygen sensing \[[@CR231]\] and subsequently the effects of this gas on cell-signalling networks \[[@CR1]\] and on S-sulfhydration of proteins \[[@CR62]\]. Recently, polymorphisms have been identified for the SQR gene, which are linked to pathophysiological conditions in humans. Jin et al. reported on the SQR I264T gene variant that increases susceptibility to osteoporosis in Korean postmenopausal women \[[@CR232]\]. In another study, genomic-wide screening in Filipino women reported that the rs12594514 SNP in the SQR gene is associated with two obesity-related phenotypes \[[@CR233]\]. Interestingly, the cellular levels of H~2~S are critical determinants in the regulation of bone remodelling \[[@CR169], [@CR232]\] and osteoclast differentiation \[[@CR234], [@CR235]\]. Moreover, it is now widely recognised that H~2~S has a range of functions linked to metabolism and obesity \[[@CR7], [@CR236]--[@CR240]\]. Therefore, it is likely that SQR has the potential to influence some of the biological effects of H~2~S in vivo. To date, there are no reported murine SQR KO models however, SQR KO *C.elegans *systems are known. Using gene knockout strategies in *C. elegans*, SQR was found to be important in the maintenance of protein translation. In SQR mutant worms, exposure to H~2~S leads to phosphorylation of eIF2α and the inhibition of protein synthesis. The authors speculating that SQR may be involved in H~2~S signalling relating to proteostasis \[[@CR241]\]. Of relevance, here is the potential link with H~2~S, proteostasis and the anti-ageing effects of this gas.

Ethylmalonic encephalopathy knockout mouse models {#Sec12}
=================================================

Another candidate protein potentially involved in H~2~S detoxification is that of ETHE1. The ETHE1 gene codes for an iron-containing protein from the metallo β-lactamase family are required in the mitochondrial sulfide oxidation pathway and for the oxidation of glutathione persulfide (GSSH) to give glutathione and persulfate \[[@CR91]\]. ETHE1 protein catalyses the second step in the mitochondrial sulfide oxidation pathway downstream of SQR. Mutations in this gene cause the rare condition known as ethylmalonic encephalopathy (EE) that affects the brain, gastrointestinal tract, and peripheral vessels \[[@CR242]\]. This inborn error of metabolism is an autosomal recessive condition that is invariably fatal and characterised by encephalopathy, microangiopathy, chronic diarrhea, and defective cytochrome c oxidase (COX) in muscle and brain \[[@CR243]\]. The latter oxidizes H~2~S to persulfide and transfers electrons to the electron transport chain via reduced quinone. Indeed, recombinant expression of human SQR is known to enhance sulfide oxidation in mammalian cells \[[@CR244]\]. More revealing insights as to the functional role of ETHE1 have been reported \[[@CR245]\]. Adopting a proteomic approach Hildbrant and colleagues conducted an analysis of ETHE1 KO mouse tissues and confirmed a role of ETHE1 in the sulfide oxidation pathway while also revealing more subtle effects on post-translational protein modifications linked to protein cysteine modification. Elevated H~2~S levels caused by loss of ETHE1 likely cause an increase in S-sulfhydration of cellular proteins via persulfide-mediated reactions \[[@CR246]\]. Of particular interest, from this work is that sulfide signalling seems to play a pivotal part in regulating mitochondrial catabolism of fatty acids and branched-chain amino acids. Interestingly, sulfide concentrations are decreased in the plasma of overweight men and low sulfide levels are associated with the development of insulin resistance in Type 2 diabetes \[[@CR247]\]. Moreover, in rats fed high-fat diets ETHE1 and SQR are reported to be decreased by more than 50% in tissues \[[@CR248]\].

Cysteine dioxygenase knockout mouse models {#Sec13}
==========================================

Finally, a common component linking all of the enzymatic systems described herein is their reliance on intermediates derived from sulfur amino-acid metabolism, specifically, the interplay between cysteine synthesis, its cellular uses, and its degradation. Cysteine homeostasis and the relative rates of synthesis versus degradation will clearly influence how and when H~2~S will be produced within tissues. This coupled with the relative rates of oxidation of both molecules further adding complexity to the H~2~S story. One particularly interesting model is the cysteine dioxygenase (CDO; EC: 1.13.11.20) KO mouse model. Ordinarily, CDO oxidizes cysteine-to-cysteine sulfinate, which is further metabolized to either taurine or to pyruvate plus sulfate. This metabolic pathway is believed to function in maintaining cysteine levels and to supply circulatory taurine. In the CDO KO mouse line, there is postnatal mortality, growth deficit, and connective tissue pathology. Moreover, KO animals have reduced taurine levels, elevated cysteine levels, and increased desulfuration in liver tissues that correlates with the elevated production of H~2~S. This reported to be due to CBS activation. Importantly, CDO null mice also exhibit lower hepatic cytochrome c oxidase levels, suggesting impaired electron transport capacity. Cytochrome c oxidase being a known cellular target prone to H~2~S-mediated inhibition. Similarly, in hepatocytes isolated from CDO null mice increased synthesis of H~2~S within cells occurs that is perhaps due to an increase in the endogenous pool of cysteine within tissues \[[@CR249]\]. Also reported in the CDO KO mice is an increase in the urinary excretion of thiosulfate, coupled with higher tissue and serum cystathionine and lanthionine levels. Importantly, the inhibition and destabilization of cytochrome c oxidase are observed that again is consistent with increased production of H~2~S \[[@CR249], [@CR250]\]. Thus, it would appear that the ability of CDO to control cysteine levels may be necessary to maintain low H~2~S/sulfane sulfur pools within tissues to facilitate the use of H~2~S as a signalling molecule \[[@CR251]\]. This model, therefore, provides a unique system to explore cysteine metabolism and its influence of H~2~S production and redox-signalling networks.

Availability of knockout mouse models for H~2~S research {#Sec14}
========================================================

At this time, it may be of interest to researchers that CBS KO mice are now commercially available and can be obtained from the Jackson laboratories which supplies the JAX^®^ Mice derived from the fully sequenced mouse strain, C57BL/6J \[[@CR252]\]. This particular line is useful for studying the in vivo role of elevated levels of homocysteine in the aetiology of cardiovascular diseases and was developed in the lab of Dr Nobuyo Maeda at the University of North Carolina at Chapel Hill. A number of researchers have utilised this mouse model to determine the functional role of H~2~S in colitis \[[@CR253]\] for the role of H~2~S in alveolarization \[[@CR254]\] and in the prevention of hyperhomocysteinemia associated chronic renal failure \[[@CR255]\], however, studies are limited primarily due to the high mortality rates in offspring. In the case of research using CSE knockout (CSE-KO) animals, this model is more widely reported in the literature. These animals have markedly reduced H~2~S levels in the serum, heart, aorta, and other tissues and mutant mice lacking CSE display pronounced hypertension and diminished endothelium-dependent vasorelaxation. Again, this model is particularly useful for studying cardiovascular disease. Although not commercially available at present several institutions maintain the CSE-KO mouse model that was originally developed in the laboratory of Rui Wang, Lakehead University, Thunder Bay, Ontario, Canada. This model is the most widely used physiologically relevant model and has been the focus of research ranging from the role of H~2~S in vasorelaxation \[[@CR204]\], to O~2~ sensing in the carotid body \[[@CR206]\]. 3-MST and ETHE1 KO animals are maintained at the Isotope Research Centre, Nippon Medical School, Tokyo and at the Institute of Neurology Carlo Besta-Istituto di Ricovero e Cura a Carattere Scientifico Foundation, Milan, Italy. Hopefully in the future, these models will become more common place in research focused on H~2~S biology.

Non-mammalian genetic models {#Sec15}
============================

The majority of work highlighting a biological role for H~2~S has been derived from mammalian models. Information derived from non-mammalian models reflects on the evolutionary importance of H~2~S and its role in biochemical and physiological processes across different taxa. Several reports now describe the homeostatic systems and physiological effects of H~2~S across a range of animal and plant systems particularly in the model organisms *C. elegans*, *D. melanogaster*, *D. rerio,* and *Arabidopsis thaliana* \[[@CR256], [@CR257]\]. The reason for this work is one of translation, since, for example, the exploitation of the H~2~S biosynthetic pathway in animals and in plants may assist in Agritech for the purpose of improving crop yields or resistance to pathogen attack. To date, only a handful of studies have been described in which the targeted deletion or overexpression of H~2~S synthesising enzymes has been manipulated in non-mammalian systems. Much of this work has utilised molecular approaches to alter the expression levels of H~2~S synthesising enzymes in the nematode worm, *C. elegans.* These studies have identified roles for H~2~S in the ageing process, in longevity, and in the health benefits attributed to caloric/dietary restriction. It is widely known that worms exposed to exogenous H~2~S have increased longevity and thermotolerance \[[@CR258], [@CR259]\]. However, direct molecular confirmations that these physiological processes can be controlled via endogenous H~2~S synthesis have only recently been described \[[@CR54], [@CR55]\]. In these studies, siRNA-mediated silencing approaches were utilised to knock down *C. elegans* targets. Deletion of CYST-2, a cysteine sulfhydrylase, caused a significant reduction in lifespan in worms exposed to stress conditions \[[@CR54]\]. This finding establishing a clear link between H~2~S synthesis and the ability of worms to adapt and recover from stress insults associated with the ageing process. Indeed, deficiency in mpst-1, mammalian 3-MST orthologue 1, reduces lifespan in *C. elegans*. It has subsequently been demonstrated in the work of Hine et al. that H~2~S production in *C. elegans* is linked to the health benefits attributed to caloric/dietary restriction. In this study, utilising siRNA technologies, individual KO experiments were performed that focused on a number of proteins associated with the trans-sulfuration pathway, namely, the cystathione-γ-lyase worm homologues CTH-1 and CTH-2 and the CBS homolog CBS-1 and CBL-1 \[[@CR260], [@CR261]\]. Loss of functional CBL-1 and CBS-2 protein appears to have no effects on longevity when expressed in the *eat*-*2* mutant worms; the *eat*-*2* mutant serving as a genetic model of life extension that mimics dietary restriction. Interestingly, *eat*-*2* worms produce more H~2~S than their wild-type counterparts. Importantly, the overexpression of CBS-1 extends the median lifespan of wild-type worms this clearly showing that H~2~S mediates the beneficial effects attributed to dietary/caloric restriction in *C. elegans*.

Similar finding has also been reported for *Drosophila melanogaster.* In this model, dietary restriction promotes the upregulation and increased activity of the trans-sulfuration pathway leading to increased tissue synthesis rates of H~2~S \[[@CR262]\]. Transgene-mediated increases in gene expression and enzyme activity of *Drosophila* cystathionine β-synthase (dCBS) are sufficient to increase fly lifespan. Moreover, the inhibition of the trans-sulfuration pathway effectively blocks the lifespan extension normally observed in diet-restricted animals. These findings are of particular interest, since they provide an additional evidence that H~2~S plays important functional roles in the ageing process of living organisms. Besides, ageing, H~2~S also appears to mediate neurodegenerative processes in *Drosophila* models. For example, overexpression of CSE in *Drosophila* suppresses spinocerebellar ataxia type 3-associated damage and neurodegeneration \[[@CR263]\]. The observed decreased in cellular damage being attributed to a reduction in oxidative stress and a reduced immune response in flies. Clearly, these findings correlate well with the known antioxidant and anti-inflammatory effects attributed to H~2~S.

Work using teleost's species, such as *Danio,* are rare, but, nonetheless, provides important information on the physiological role of H~2~S. In the work of Kumai et al., H~2~S was found to influence Na^+^ homeostatic regulation in the larva of *D. rerio* \[[@CR264]\]. Translational gene knockdown was used to reduce CSE expression in tissues. Using this approach Kumai and colleagues were able to elegantly demonstrate that H~2~S is an endogenous inhibitor of Na^+^ uptake in developing zebrafish.

Conclusions {#Sec16}
===========

Over the last decade, considerable evidence has been accumulated which collectively points to a functional role for H~2~S in a number of physiological systems. Much of these data have been derived from pharmacological intervention in which inhibition of enzymatic systems linked to the production of H~2~S has been targeted or via direct drug targeting using small molecular weight H~2~S donor molecules. Invariably, these studies have highlighted a role of H~2~S levels within a number of pathophysiological states and that restoration of tissue H~2~S levels is protective in the majority of cases. Despite the current knowledge, and continued breakthroughs, one can envisage that transgenic models will be at the forefront of future work in this area. Developments based on the approach taken by Mani et al. in which a double knockout mouse model in which both the CSE and the apolipoprotein E gene are silenced may be particularly revealing \[[@CR212]\]. Studies using these models have been fruitful and have shown how changes in cellular H~2~S levels influence physiological processes. Yet, the true power of these models is still to be realised. Since the discovery that cross talk exists between H~2~S with other gaseous signalling molecules, such as NO, the use of transgenic models in which one or both sets of synthesising enzymes are silenced may be invaluable in future studies. Data on the interactions of NO with H~2~S are only just emerging and it would be fascinating to explore the effects of incorporating the CSE-KO background into other transgenic systems such as that of iNOS \[[@CR265]\] or eNOS KO \[[@CR266], [@CR267]\] mouse models. How would the loss of each gas alter the formation and levels of circulatory nitrosothiols for example? What would be the consequences of this systemically? Could biologically active persulfides compensate for the loss of nitrosothiols? More revealing is the current evidence showing that both gases can influence mitochondrial function, energy metabolism, and tissue homeostasis, but the functional consequences of combined defects in H~2~S and NO production are not known. Could these interactions, or lack off, underpin dysregulation in metabolism as seen in diabetes or obesity? The development of these models would also be particularly useful in the screening of H~2~S/NO hybrid donor drugs \[[@CR268]--[@CR270]\]. Finally, could double knockout models be developed to explore the influence of H~2~S detoxification enzymes on cardiovascular function and on inflammatory responses in animals? What, for example, would be the effect of loss of CBS, or 3-MST in the apolipoprotein E KO murine model? Would this further predisposes animals to atherosclerosis, and would similar effects be found with the overexpression of SQR and ETHE1? With the development of these transgenic models, there are certainly more questions than answers and much remains to be explored regarding the role of this gas within biological systems. Hopefully, a greater understanding will come from the use of these newer tools that will hopefully assist in the development and introduction of new H~2~S releasing pro-drugs within the clinic.
